Shell Plc 1st Quarter 2025 Unaudited Results
Shell's Q1 2025 results highlight a 415% rise in shareholder income and a 52% increase in adjusted earnings compared to Q4 2024. Despite notable charges, the company maintained strong free cash flow and continued strategic investments, including portfolio expansions in integrated gas and upstream sectors. Overall, Shell demonstrated resilience through fluctuating market conditions.
Gfinity PLC - Corporate update
Gfinity PLC provides updates on its partnership with 0M Technology Solutions Ltd to commercialize the Connected IQ AI platform, marking initial revenues in April. It has also launched Yentra.AI, a venture offering AI consulting and engineering services. The company plans to expand its sales team and enhance its AI technologies to seize opportunities in the growing AI market.
Hemogenyx Pharma Plc - Second Patient Treated with HG-CT-1 CAR-T Therapy
Hemogenyx Pharmaceuticals plc announces the successful treatment of a second patient in its Phase I trial of HG-CT-1 CAR-T therapy for relapsed or refractory acute myeloid leukemia (AML) in adults. This milestone underscores progress in developing a potentially transformative treatment, addressing unmet needs in hematologic malignancies, and aiming towards future pediatric trials.
Prospex Energy PLC - Q1 2025 Activity Report
Prospex Energy plc's update on the Selva Malvezzi production concession in Italy highlights steady gas production and robust revenues in Q1 2025. The company, with a 37% working interest, reports a gross quarterly production of 6.724 MMscm and revenues of €1.235 million. Preparations for four new wells and a 3D geophysical survey are underway.
Nuformix PLC - Half-year Report
Nuformix plc (LSE: NFX), a pharmaceutical development company, reports its unaudited results for the six months ended 31 March 2025. Focusing on drug repurposing for fibrosis and oncology, highlights include NXP002's promising results for treating fibrotic lung diseases and obtaining a positive opinion for Orphan Drug Designation in IPF from the EMA. Financially, the Group reported a post-tax loss of £376,668.
Xtract Resources plc - Silverking Project Drilling Update
Xtract Resources Plc reports promising assay results from the Silverking Project in Zambia. Highlights include significant copper and silver intercepts over substantial mineralised widths, and an extended strike length to over 160 meters. Expanded metallurgical testing suggests potential to enhance production by upgrading lower grade mineralisation using gravity processes. Updates continue as new data emerges.
Harbour Energy PLC - Southern Energy SA – Final Investment Decision
Harbour Energy, alongside partners Pan American Energy, YPF, Pampa Energia, and Golar LNG, has reached a Final Investment Decision for the Southern Energy FLNG export project in Argentina. The project aims to start LNG production by 2027-2028, with Harbour's investment peaking at $100 million, capitalising under new investment incentives.
Kavango Resources - ZIM: Prospect 3 Positive Assay Results
Kavango Resources PLC reports promising assay results from Prospect 3, part of the Hillside Gold Project in Zimbabwe. Drilling reveals higher-than-expected gold grades across six mineralised zones, indicating potential for near-term open-pit mining and future underground mechanised mining. The next phase involves further drilling to explore mineralisation depth and extent.
Shell plc First Quarter 2025 Interim Dividend
Shell plc has announced an interim dividend of US$ 0.358 per ordinary share for Q1 2025. Shareholders can opt to receive dividends in US dollars, euros, or pounds sterling, with equivalents announced on June 9, 2025. Payment is scheduled for June 23, 2025. The DRIP options allow reinvestment in Shell shares.
Pearson PLC - Pearson Q1 2025 Trading Update
Pearson reports a 1% increase in Q1 underlying group sales, with higher growth anticipated in the second half of 2025. Despite economic uncertainties, all business units perform as expected. Strategic initiatives include new learning tools and partnerships, alongside a £350m share buyback. CTO Dave Treat assumes a larger tech role following executive changes.